Literature DB >> 3693254

Fatal hemolysis due to unidentified causes following mitral valve replacement with bileaflet tilting disc valve prosthesis.

Y Morishita1, K Arikawa, M Yamashita, T Yuda, S Shimokawa, H Saigenji, M Hashiguchi, A Taira.   

Abstract

Fatal hemolysis after mitral valve replacement with the St. Jude bileaflet tilting prosthesis is reported in two patients. Although one underwent re-replacement of the valve, both died from multiple organ failure and acute renal failure, respectively. Scanning electron microscopy revealed microthrombi adherent to a leaflet in one and irregular leaflet surfaces in the other. Such defects are rare but are possible causes of hemolysis in patients with the St. Jude mitral valve prosthesis.

Entities:  

Mesh:

Year:  1987        PMID: 3693254     DOI: 10.1007/bf02058527

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  10 in total

1.  FATAL HEMOLYSIS FOLLOWING BALL VALVE REPLACEMENT OF THE AORTIC VALVE.

Authors:  W A REED; M DUNN
Journal:  J Thorac Cardiovasc Surg       Date:  1964-09       Impact factor: 5.209

2.  HEMOLYTIC ANEMIA COMPLICATING AORTIC-VALVE SURGERY. AN AUTOIMMUNE SYNDROME.

Authors:  B PIROFSKY; D W SUTHERLAND; A STARR; H E GRISWOLD
Journal:  N Engl J Med       Date:  1965-02-04       Impact factor: 91.245

3.  Complications of artificial heart valves.

Authors:  F E Kloster
Journal:  JAMA       Date:  1979-05-18       Impact factor: 56.272

4.  Factors influencing hemolysis in valve prosthesis.

Authors:  C Crexells; N Aerichide; Y Bonny; G Lepage; L Campeau
Journal:  Am Heart J       Date:  1972-08       Impact factor: 4.749

5.  Hemodynamic and hemolytic features of the St. Jude Medical valve prostheses.

Authors:  Y Sezai; S Umeda; T Okazaki; I Okamoto; H Rikukawa; M Shiono
Journal:  J Cardiovasc Surg (Torino)       Date:  1984 Jan-Feb       Impact factor: 1.888

6.  Six years of experience with the St. Jude Medical valvular prosthesis.

Authors:  K V Arom; D M Nicoloff; T E Kersten; W F Northrup; W G Lindsay
Journal:  Circulation       Date:  1985-09       Impact factor: 29.690

7.  A 5 1/2 year experience with the St. Jude Medical cardiac valve prosthesis. Early and late results of 737 valve replacements in 671 patients.

Authors:  E M Baudet; C C Oca; X F Roques; M N Laborde; A S Hafez; M A Collot; I M Ghidoni
Journal:  J Thorac Cardiovasc Surg       Date:  1985-07       Impact factor: 5.209

8.  Durability and low thrombogenicity of the St. Jude Medical valve at 5-year follow-up.

Authors:  J M Duncan; D A Cooley; G J Reul; D A Ott; G L Hallman; O H Frazier; J J Livesay; W E Walker; P R Adams
Journal:  Ann Thorac Surg       Date:  1986-11       Impact factor: 4.330

9.  Clinical comparison of St. Jude and porcine aortic valve prostheses.

Authors:  P S Douglas; J W Hirshfeld; R N Edie; A H Harken; L W Stephenson; L H Edmunds
Journal:  Circulation       Date:  1985-09       Impact factor: 29.690

10.  Clinical evaluation of the St. Jude Medical heart valve prosthesis. A two-year follow-up of 150 patients.

Authors:  D Burckhardt; A Hoffmann; S Vogt; M Pfisterer; J Hasse; E Grädel
Journal:  J Thorac Cardiovasc Surg       Date:  1984-09       Impact factor: 5.209

  10 in total
  4 in total

1.  Numerical simulation of instantaneous backflow through central clearance of bileaflet mechanical heart valves at closure: shear stress and pressure fields within clearance.

Authors:  C S Lee; K B Chandran
Journal:  Med Biol Eng Comput       Date:  1995-05       Impact factor: 2.602

2.  Instantaneous back flow through peripheral clearance of Medtronic Hall tilting disc valve at the moment of closure.

Authors:  C S Lee; K B Chandran
Journal:  Ann Biomed Eng       Date:  1994 Jul-Aug       Impact factor: 3.934

3.  The necessity of reoperation for patients with Bjork-Shiley, St Jude Medical, Hancock and Carpentier-Edwards prostheses.

Authors:  Y Morishita; H Toyohira; T Yuda; Y Umebayashi; H Saigenji; M Hashiguchi; K Uehara; A Taira
Journal:  Jpn J Surg       Date:  1990-07

4.  Multiple organ failure after mitral valve repair with intravascular hemolysis and its recovery due to mitral valve replacement.

Authors:  M Seyr; W Hasibeder; W Furtwaegler; H Antretter; N J Mutz
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.